Global Insulin Drug and Delivery Technologies Market Research Report 2019

Published On: Apr 2019

Format: PDF

Publisher: QY Research

Pages: 92

Report ID: 259298

Insulin is a protein hormone that is used as a medication to treat high blood glucose. This includes in diabetes mellitus type 1, diabetes mellitus type 2, gestational diabetes, and complications of diabetes such as diabetic ketoacidosis and hyperosmolar hyperglycemic states. It is also used along with glucose to treat high blood potassium levels. Typically it is given by injection under the skin, but some forms may also be used by injection into a vein or muscle.
The emerging technologies in the insulin drug and delivery field have potential in the diabetes market, with improved glucose control, along with improved and well-accepted newer delivery methods. Modern industries and research institutes have begun to explore newer method for diabetes control in adults and juveniles, leading to a steady market for these technologies. Research and development (R&D) spending, increasing competition, patent expiries and emerging technologies are guiding this to a new direction. The new advancements, new product launches, and increased awareness and early detection of the disease have influenced the market to grow in the foreseeable future.

The global Insulin Drug and Delivery Technologies market is valued at 36000 million US$ in 2018 is expected to reach 67500 million US$ by the end of 2025, growing at a CAGR of 9.4% during 2019-2025.
This report focuses on Insulin Drug and Delivery Technologies volume and value at global level, regional level and company level. From a global perspective, this report represents overall Insulin Drug and Delivery Technologies market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Sanofi
Eli Lilly and Company
Biocon
Julphar
Ypsomed
Becton, Dickinson and Company
...

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Insulin Syringes
Insulin Vials
Insulin Pens
Insulin Pumps

Segment by Application
Diabetes Mellitus Type 1
Diabetes Mellitus Type 2
Gestational Diabetes

Table of Contents

Executive Summary
1 Insulin Drug and Delivery Technologies Market Overview
1.1 Product Overview and Scope of Insulin Drug and Delivery Technologies
1.2 Insulin Drug and Delivery Technologies Segment by Type
1.2.1 Global Insulin Drug and Delivery Technologies Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Insulin Syringes
1.2.3 Insulin Vials
1.2.4 Insulin Pens
1.2.5 Insulin Pumps
1.3 Insulin Drug and Delivery Technologies Segment by Application
1.3.1 Insulin Drug and Delivery Technologies Consumption Comparison by Application (2014-2025)
1.3.2 Diabetes Mellitus Type 1
1.3.3 Diabetes Mellitus Type 2
1.3.4 Gestational Diabetes
1.4 Global Insulin Drug and Delivery Technologies Market by Region
1.4.1 Global Insulin Drug and Delivery Technologies Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Insulin Drug and Delivery Technologies Market Size
1.5.1 Global Insulin Drug and Delivery Technologies Revenue (2014-2025)
1.5.2 Global Insulin Drug and Delivery Technologies Production (2014-2025)

2 Global Insulin Drug and Delivery Technologies Market Competition by Manufacturers
2.1 Global Insulin Drug and Delivery Technologies Production Market Share by Manufacturers (2014-2019)
2.2 Global Insulin Drug and Delivery Technologies Revenue Share by Manufacturers (2014-2019)
2.3 Global Insulin Drug and Delivery Technologies Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Insulin Drug and Delivery Technologies Production Sites, Area Served, Product Types
2.5 Insulin Drug and Delivery Technologies Market Competitive Situation and Trends
2.5.1 Insulin Drug and Delivery Technologies Market Concentration Rate
2.5.2 Insulin Drug and Delivery Technologies Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Insulin Drug and Delivery Technologies Production Market Share by Regions
3.1 Global Insulin Drug and Delivery Technologies Production Market Share by Regions
3.2 Global Insulin Drug and Delivery Technologies Revenue Market Share by Regions (2014-2019)
3.3 Global Insulin Drug and Delivery Technologies Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Insulin Drug and Delivery Technologies Production
3.4.1 North America Insulin Drug and Delivery Technologies Production Growth Rate (2014-2019)
3.4.2 North America Insulin Drug and Delivery Technologies Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Insulin Drug and Delivery Technologies Production
3.5.1 Europe Insulin Drug and Delivery Technologies Production Growth Rate (2014-2019)
3.5.2 Europe Insulin Drug and Delivery Technologies Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Insulin Drug and Delivery Technologies Production (2014-2019)
3.6.1 China Insulin Drug and Delivery Technologies Production Growth Rate (2014-2019)
3.6.2 China Insulin Drug and Delivery Technologies Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Insulin Drug and Delivery Technologies Production (2014-2019)
3.7.1 Japan Insulin Drug and Delivery Technologies Production Growth Rate (2014-2019)
3.7.2 Japan Insulin Drug and Delivery Technologies Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Insulin Drug and Delivery Technologies Consumption by Regions
4.1 Global Insulin Drug and Delivery Technologies Consumption by Regions
4.2 North America Insulin Drug and Delivery Technologies Consumption (2014-2019)
4.3 Europe Insulin Drug and Delivery Technologies Consumption (2014-2019)
4.4 China Insulin Drug and Delivery Technologies Consumption (2014-2019)
4.5 Japan Insulin Drug and Delivery Technologies Consumption (2014-2019)

5 Global Insulin Drug and Delivery Technologies Production, Revenue, Price Trend by Type
5.1 Global Insulin Drug and Delivery Technologies Production Market Share by Type (2014-2019)
5.2 Global Insulin Drug and Delivery Technologies Revenue Market Share by Type (2014-2019)
5.3 Global Insulin Drug and Delivery Technologies Price by Type (2014-2019)
5.4 Global Insulin Drug and Delivery Technologies Production Growth by Type (2014-2019)

6 Global Insulin Drug and Delivery Technologies Market Analysis by Applications
6.1 Global Insulin Drug and Delivery Technologies Consumption Market Share by Application (2014-2019)
6.2 Global Insulin Drug and Delivery Technologies Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Insulin Drug and Delivery Technologies Business
7.1 Sanofi
7.1.1 Sanofi Insulin Drug and Delivery Technologies Production Sites and Area Served
7.1.2 Insulin Drug and Delivery Technologies Product Introduction, Application and Specification
7.1.3 Sanofi Insulin Drug and Delivery Technologies Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 Eli Lilly and Company
7.2.1 Eli Lilly and Company Insulin Drug and Delivery Technologies Production Sites and Area Served
7.2.2 Insulin Drug and Delivery Technologies Product Introduction, Application and Specification
7.2.3 Eli Lilly and Company Insulin Drug and Delivery Technologies Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 Biocon
7.3.1 Biocon Insulin Drug and Delivery Technologies Production Sites and Area Served
7.3.2 Insulin Drug and Delivery Technologies Product Introduction, Application and Specification
7.3.3 Biocon Insulin Drug and Delivery Technologies Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 Julphar
7.4.1 Julphar Insulin Drug and Delivery Technologies Production Sites and Area Served
7.4.2 Insulin Drug and Delivery Technologies Product Introduction, Application and Specification
7.4.3 Julphar Insulin Drug and Delivery Technologies Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 Ypsomed
7.5.1 Ypsomed Insulin Drug and Delivery Technologies Production Sites and Area Served
7.5.2 Insulin Drug and Delivery Technologies Product Introduction, Application and Specification
7.5.3 Ypsomed Insulin Drug and Delivery Technologies Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served
7.6 Becton, Dickinson and Company
7.6.1 Becton, Dickinson and Company Insulin Drug and Delivery Technologies Production Sites and Area Served
7.6.2 Insulin Drug and Delivery Technologies Product Introduction, Application and Specification
7.6.3 Becton, Dickinson and Company Insulin Drug and Delivery Technologies Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business and Markets Served

8 Insulin Drug and Delivery Technologies Manufacturing Cost Analysis
8.1 Insulin Drug and Delivery Technologies Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Insulin Drug and Delivery Technologies
8.4 Insulin Drug and Delivery Technologies Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Insulin Drug and Delivery Technologies Distributors List
9.3 Insulin Drug and Delivery Technologies Customers

10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors

11 Global Insulin Drug and Delivery Technologies Market Forecast
11.1 Global Insulin Drug and Delivery Technologies Production, Revenue Forecast
11.1.1 Global Insulin Drug and Delivery Technologies Production Growth Rate Forecast (2019-2025)
11.1.2 Global Insulin Drug and Delivery Technologies Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Insulin Drug and Delivery Technologies Price and Trend Forecast (2019-2025)
11.2 Global Insulin Drug and Delivery Technologies Production Forecast by Regions (2019-2025)
11.2.1 North America Insulin Drug and Delivery Technologies Production, Revenue Forecast (2019-2025)
11.2.2 Europe Insulin Drug and Delivery Technologies Production, Revenue Forecast (2019-2025)
11.2.3 China Insulin Drug and Delivery Technologies Production, Revenue Forecast (2019-2025)
11.2.4 Japan Insulin Drug and Delivery Technologies Production, Revenue Forecast (2019-2025)
11.3 Global Insulin Drug and Delivery Technologies Consumption Forecast by Regions (2019-2025)
11.3.1 North America Insulin Drug and Delivery Technologies Consumption Forecast (2019-2025)
11.3.2 Europe Insulin Drug and Delivery Technologies Consumption Forecast (2019-2025)
11.3.3 China Insulin Drug and Delivery Technologies Consumption Forecast (2019-2025)
11.3.4 Japan Insulin Drug and Delivery Technologies Consumption Forecast (2019-2025)
11.4 Global Insulin Drug and Delivery Technologies Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Insulin Drug and Delivery Technologies Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer